FDA Drug Safety Communication: FDA to review heart failure risk with diabetes drug saxagliptin (marketed as Onglyza and Kombiglyze XR)

<!–

–>

<!–

• Page Last Updated: 02/11/2014

–>
Page Last Updated: 02/11/2014
<!–

–>

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.